Clinical trial

Immunoadsorption vs. Plasmapheresis in the Escalation Therapy of Relapse in Multiple Sclerosis

NCT02671682

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2016-02-26

PhaseNA

Study timeline

Study start (actual)2016-02-26Date precision: day

Registry last updated2019-09-11

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Multiple Sclerosisunresolved

Clinically Isolated Syndromeunresolved

Interventions

ImmunoadsorptionPROCEDURE

PlasmapheresisPROCEDURE

Sponsors & collaborators

Albert Christian Ludolph, Prof.lead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02671682 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.